Literature DB >> 19826052

Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination.

Sophie Pinner1, Peter Jordan, Kirsty Sharrock, Laura Bazley, Lucy Collinson, Richard Marais, Elise Bonvin, Colin Goding, Erik Sahai.   

Abstract

How melanoma acquire a metastatic phenotype is a key issue. One possible mechanism is that metastasis is driven by microenvironment-induced switching between noninvasive and invasive states. However, whether switching is a reversible or hierarchical process is not known and is difficult to assess by comparison of primary and metastatic tumors. We address this issue in a model of melanoma metastasis using a novel intravital imaging method for melanosomes combined with a reporter construct in which the Brn-2 promoter drives green fluorescent protein (GFP) expression. A subpopulation of cells containing little or no pigment and high levels of Brn2::GFP expression are motile in the primary tumor and enter the vasculature. Significantly, the less differentiated state of motile and intravasated cells is not maintained at secondary sites, implying switching between states as melanoma cells metastasize. We show that melanoma cells can switch in both directions between high- and low-pigment states. However, switching from Brn2::GFP high to low was greatly favored over the reverse direction. Microarray analysis of high- and low-pigment populations revealed that transforming growth factor (TGF)beta2 was up-regulated in the poorly pigmented cells. Furthermore, TGFbeta signaling induced hypopigmentation and increased cell motility. Thus, a subset of less differentiated cells exits the primary tumor but subsequently give rise to metastases that include a range of more differentiated and pigment-producing cells. These data show reversible phenotype switching during melanoma metastasis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19826052      PMCID: PMC2763120          DOI: 10.1158/0008-5472.CAN-09-0781

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

Review 1.  The regulation of skin pigmentation.

Authors:  Yuji Yamaguchi; Michaela Brenner; Vincent J Hearing
Journal:  J Biol Chem       Date:  2007-07-16       Impact factor: 5.157

2.  Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature.

Authors:  Keith S Hoek; Natalie C Schlegel; Patricia Brafford; Antje Sucker; Selma Ugurel; Rajiv Kumar; Barbara L Weber; Katherine L Nathanson; David J Phillips; Meenhard Herlyn; Dirk Schadendorf; Reinhard Dummer
Journal:  Pigment Cell Res       Date:  2006-08

3.  Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.

Authors:  Suzanne Carreira; Jane Goodall; Laurence Denat; Mercedes Rodriguez; Paolo Nuciforo; Keith S Hoek; Alessandro Testori; Lionel Larue; Colin R Goding
Journal:  Genes Dev       Date:  2006-12-15       Impact factor: 11.361

Review 4.  Melanocytes and the microphthalmia transcription factor network.

Authors:  Eiríkur Steingrímsson; Neal G Copeland; Nancy A Jenkins
Journal:  Annu Rev Genet       Date:  2004       Impact factor: 16.830

5.  Transforming growth factor-beta1 inhibits basal melanogenesis in B16/F10 mouse melanoma cells by increasing the rate of degradation of tyrosinase and tyrosinase-related protein-1.

Authors:  M Martínez-Esparza; C Jiménez-Cervantes; F Beermann; P Aparicio; J A Lozano; J C García-Borrón
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

6.  The POU domain transcription factor Brn-2: elevated expression in malignant melanoma and regulation of melanocyte-specific gene expression.

Authors:  T Eisen; D J Easty; D C Bennett; C R Goding
Journal:  Oncogene       Date:  1995-11-16       Impact factor: 9.867

7.  Microphthalmia-associated transcription factor (MITF) is required but is not sufficient to induce the expression of melanogenic genes.

Authors:  Cédric Gaggioli; Roser Buscà; Patricia Abbe; Jean-Paul Ortonne; Robert Ballotti
Journal:  Pigment Cell Res       Date:  2003-08

Review 8.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits.

Authors:  Kornelia Polyak; Robert A Weinberg
Journal:  Nat Rev Cancer       Date:  2009-03-05       Impact factor: 60.716

9.  Inhibition of PAX3 by TGF-beta modulates melanocyte viability.

Authors:  Guang Yang; Yitang Li; Emi K Nishimura; Hong Xin; Anyu Zhou; Yinshi Guo; Liang Dong; Mitchell F Denning; Brian J Nickoloff; Rutao Cui
Journal:  Mol Cell       Date:  2008-11-21       Impact factor: 17.970

10.  Efficient tumour formation by single human melanoma cells.

Authors:  Elsa Quintana; Mark Shackleton; Michael S Sabel; Douglas R Fullen; Timothy M Johnson; Sean J Morrison
Journal:  Nature       Date:  2008-12-04       Impact factor: 49.962

View more
  86 in total

Review 1.  Intravital microscopy: a novel tool to study cell biology in living animals.

Authors:  Roberto Weigert; Monika Sramkova; Laura Parente; Panomwat Amornphimoltham; Andrius Masedunskas
Journal:  Histochem Cell Biol       Date:  2010-04-07       Impact factor: 4.304

2.  Comparison of Xiphophorus and human melanoma transcriptomes reveals conserved pathway interactions.

Authors:  Yuan Lu; Mikki Boswell; William Boswell; Susanne Kneitz; Michael Hausmann; Barbara Klotz; Janine Regneri; Markita Savage; Angel Amores; John Postlethwait; Wesley Warren; Manfred Schartl; Ronald Walter
Journal:  Pigment Cell Melanoma Res       Date:  2018-01-29       Impact factor: 4.693

3.  FOXD3 modulates migration through direct transcriptional repression of TWIST1 in melanoma.

Authors:  Michele B Weiss; Ethan V Abel; Neda Dadpey; Andrew E Aplin
Journal:  Mol Cancer Res       Date:  2014-07-24       Impact factor: 5.852

4.  BORIS/CTCFL promotes a switch from a proliferative towards an invasive phenotype in melanoma cells.

Authors:  Sanne Marlijn Janssen; Roy Moscona; Mounib Elchebly; Andreas Ioannis Papadakis; Margaret Redpath; Hangjun Wang; Eitan Rubin; Léon Cornelis van Kempen; Alan Spatz
Journal:  Cell Death Discov       Date:  2020-01-02

5.  Frontiers in Intravital Multiphoton Microscopy of Cancer.

Authors:  Louisiane Perrin; Battuya Bayarmagnai; Bojana Gligorijevic
Journal:  Cancer Rep (Hoboken)       Date:  2019-06-20

Review 6.  Pro-survival role of MITF in melanoma.

Authors:  Mariusz L Hartman; Malgorzata Czyz
Journal:  J Invest Dermatol       Date:  2014-08-21       Impact factor: 8.551

Review 7.  Role of EZH2 histone methyltrasferase in melanoma progression and metastasis.

Authors:  Fade Mahmoud; Bradley Shields; Issam Makhoul; Laura F Hutchins; Sara C Shalin; Alan J Tackett
Journal:  Cancer Biol Ther       Date:  2016-04-22       Impact factor: 4.742

Review 8.  Starvation and Pseudo-Starvation as Drivers of Cancer Metastasis through Translation Reprogramming.

Authors:  Custodia García-Jiménez; Colin R Goding
Journal:  Cell Metab       Date:  2018-12-20       Impact factor: 27.287

Review 9.  Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?

Authors:  Michael Hölzel; Anton Bovier; Thomas Tüting
Journal:  Nat Rev Cancer       Date:  2013-03-28       Impact factor: 60.716

10.  A Quantitative System for Studying Metastasis Using Transparent Zebrafish.

Authors:  Silja Heilmann; Kajan Ratnakumar; Erin Langdon; Emily Kansler; Isabella Kim; Nathaniel R Campbell; Elizabeth Perry; Amy McMahon; Charles Kaufman; Ellen van Rooijen; William Lee; Christine Iacobuzio-Donahue; Richard Hynes; Leonard Zon; Joao Xavier; Richard White
Journal:  Cancer Res       Date:  2015-08-17       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.